Table 3.
Serum concentrations of vitamin D, IL-2, IL-6, IL-7, and IL-10 in patients with RA before and after treatment with rituximab
| Analyte | Before treatment (mean ± SD) | After treatment (mean ± SD) | P value |
|---|---|---|---|
| Serum vitamin D (nmol/L) | 15.35 ± 1.09 | 16.75 ± 1.2 | 0.39 |
| Serum IL-2 (pg/mL) | 52.56 ± 6.29 | 8.77 ± 1.81 | 0.0001 |
| Serum IL-6 (pg/mL) | 34.56 ± 5.01 | 21.32 ± 2.99 | 0.01 |
| Serum IL-7 (pg/mL) | 146.63 ± 9.23 | 68.71 ± 11.63 | 0.001 |
| Serum IL-10 (pg/mL) | 32.26 ± 6.01 | 17.21 ± 2.84 | 0.01 |
Abbreviations: IL, interleukin; RA, rheumatoid artritis; SD, standard deviation.